Better treatment of XDR tuberculosis needed in South Africa

Lancet. 2014 Aug 16;384(9943):581-582. doi: 10.1016/S0140-6736(14)61359-3.

Authors

Helen Cox¹, Gilles van Cutsem², Vivian Cox³

Affiliations

¹ Medical Microbiology, University of Cape Town, 7925 Cape Town, South Africa. Electronic address: helen.cox@uct.ac.za.
² Médecins sans Frontières, Cape Town, South Africa.
³ Médecins sans Frontières, Khayelitsha, South Africa.

PMID: 25131975
DOI: 10.1016/S0140-6736(14)61359-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents / therapeutic use*
Extensively Drug-Resistant Tuberculosis / drug therapy*
Female
Humans
Male

Substances

Antitubercular Agents